Novel curcumin analogs to overcome EGFR-TKI lung adenocarcinoma drug resistance and reduce EGFR-TKI-induced GI adverse effects

Novel curcumin analogs to overcome EGFR-TKI lung adenocarcinoma drug resistance and reduce EGFR-TKI-induced GI adverse effects

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Bioorganic & Medicinal Chemistry - Volume 23, Issue 7, 1 April 2015, Pages 1507-1514

Koji Wada, Jen-Yi Lee, Hsin-Yi Hung, Qian Shi, Li Lin, Yu Zhao, Masuo Goto, Pan-Chyr Yang, Sheng-Chu Kuo, Hui-Wen Chen, Kuo-Hsiung Lee,